<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been suggested that increased <z:chebi fb="105" ids="17234">glucose</z:chebi>/<z:chebi fb="105" ids="17234">glucose</z:chebi> 6-phosphate substrate cycling impairs net hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake in Type 2 (non-insulin-dependent) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and contributes to <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate <z:chebi fb="105" ids="17234">glucose</z:chebi>/<z:chebi fb="105" ids="17234">glucose</z:chebi> 6-phosphate cycle activity and insulin action in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> we studied eight patients and eight healthy control subjects, using the euglycaemic <z:chebi fb="105" ids="17234">glucose</z:chebi> clamp and isotope dilution techniques with purified [2-3H]- and [6-3H] <z:chebi fb="105" ids="17234">glucose</z:chebi> tracers, in the post-absorptive state and eight patients and five healthy control subjects during consecutive insulin infusions at rates of 0.4 and 2.0 mU.kg-1 x min-1 </plain></SENT>
<SENT sid="2" pm="."><plain>[2-3H]<z:chebi fb="105" ids="17234">glucose</z:chebi> and [6-3H]<z:chebi fb="105" ids="17234">glucose</z:chebi> radioactivity in plasma samples were determined using selective enzymatic detritiation, allowing calculation of <z:chebi fb="105" ids="17234">glucose</z:chebi> turnover rates for each isotope, the difference being <z:chebi fb="105" ids="17234">glucose</z:chebi>/<z:chebi fb="105" ids="17234">glucose</z:chebi> 6-phosphate cycling </plain></SENT>
<SENT sid="3" pm="."><plain>Endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production ([6-3H]<z:chebi fb="105" ids="17234">glucose</z:chebi>) was greater in diabetic than control subjects in the post-absorptive state (15.6 +/- 1.5 vs 11.3 +/- 0.4 mumol.kg-1 x min-1, p &lt; 0.05) and during the 0.4 mU insulin infusion (10.1 +/- 1.3 vs 5.2 +/- 0.3 mumol.kg-1 x min-1, p &lt; 0.01) indicating hepatic <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi>/<z:chebi fb="105" ids="17234">glucose</z:chebi> 6-phosphate cycling was significantly greater in diabetic than in control subjects in the post-absorptive state (2.6 +/- 0.4 vs 1.6 +/- 0.2 mumol.kg-1 x min-1, p &lt; 0.05) but not during the 0.4 mU insulin infusion (2.0 +/- 0.4 vs 2.0 +/- 0.3 mumol.kg-1 x min-1).(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>